Vice President, Marketing and Business Development @ (December 2014 - February 2020)
Global Group Marketing Director, Pulmonary @ (August 2013 - December 2014)
Integration and Commercialization Lead @ (September 2010 - July 2013)
Global Marketing Director, Endoscopy @ (October 2008 - October 2010)
Director, Clinical Strategic Partnerships @ (January 2008 - October 2008)
Director, Corporate R and D @ (August 2006 - December 2007)
Vice President @ (September 2001 - July 2006)
Cofounder @ Cybericas (November 1999 - September 2000)
Strategy Consultant @ (January 1995 - January 1999)
Beran Rose Education
MIT Sloan School of Management
MBA (Technology Marketing)
1999-2001
Yale University
BA (Political Science)
1991-1995
Beran Rose Skills
Acquisition Integration
Analysis
Analytics
Biotechnology
Business Development
Business Strategy
Capital Equipment
Clinical Trials
Commercialization
Competitive Analysis
Consulting
Cross-functional Team Leadership
Customer Research
Entrepreneurship
FDA
Global Marketing
Healthcare
International Marketing
Leadership
Life Sciences
Lifesciences
Management
Market
Market Analysis
Market Development
Market Research
Marketing
Marketing Strategy
Medical Devices
Mergers
Mergers & Acquisitions
P&L Management
Product Development
Product Launch
Product Management
Product Marketing
R&D
Research and Development (R&D)
Segmentation
Start-ups
Strategic Partnerships
Strategic Planning
Strategy
U.S. Food and Drug Administration (FDA)
Venture Capital
Beran Rose Summary
Beran Rose, based in Washington, DC, US, is currently a Chief Commercial Officer at Pulmonx Corporation. Beran Rose brings experience from previous roles at Pulmonx Corporation and Boston Scientific. Beran Rose holds a 1999 - 2001 MBA in Technology Marketing @ MIT Sloan School of Management. With a robust skill set that includes Acquisition Integration, Analysis, Analytics, Biotechnology, Business Development and more. Beran Rose has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Beran Rose?
Find contact details for 700 million professionals.